Water → 4-Piperazin-1-yl-quinoline

HRID 333944Notes

Reaction equation

HRID 333944 reaction equation
Cl[C:2]1[C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[N:5]=[CH:4][CH:3]=1.[NH:12]1[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]1.O.[OH-].[Na+]>CC(N(C)C)=O>[N:12]1([C:2]2[C:11]3[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=3)[N:5]=[CH:4][CH:3]=2)[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]1

Participants

6

Conditions

Temperature
130 °C

Procedure

4-Chloroquinoline (25 g, 0.153 mol) and anhydrous piperazine (59.2 g, 0.69 mol) were dissolved in dimethylacetamide (400 ml) and stirred at 130° C. for 4 hours. The mixture was allowed to reach room temperature, water (600 ml) and 2M NaOH (150 ml) were added and the mixture was extracted with dichloromethane (600 ml). The organic phase was dried over magnesium sulfate, the solvent was removed at reduced pressure and the residue crystallized with diisopropylether. The raw product was mixed with a mixture of dichloromethane, diisopropylether and ethyl acetate (1:1:1), and stirred overnight at room temperature. The mixture was filtered, the filtrate evaporated under reduced pressure and the residue crystallized with diisopropylether to yield 10.0 g of off-white crystals (0.047 mol, 31%). NMR (1H, CDCl3, 300 MHz): 8.74 (s, 1H), 8.04 (m, 2H), 7.65 (m, 1H), 7.48 (m, 1H), 6.85 (d, 1H), 3.19 (m, 8H).

Workup

  1. customto reach room temperature
  2. extractionthe mixture was extracted with dichloromethane (600 ml)
  3. dry with materialThe organic phase was dried over magnesium sulfate
  4. customthe solvent was removed at reduced pressure
  5. customthe residue crystallized with diisopropylether
  6. additionThe raw product was mixed with a mixture of dichloromethane, diisopropylether and ethyl acetate (1:1:1)
  7. stirringstirred overnight at room temperature
  8. filtrationThe mixture was filtered
  9. customthe filtrate evaporated under reduced pressure
  10. customthe residue crystallized with diisopropylether

Sources & evidence

ORD record
ord-4635ed7753d849719aa950dd72e38619
Source dataset
uspto-grants-2014_11
Patent number
US08883791B2

Reaction notes

Loading…